3D-living systems to model life
Research PIECES is a Deeptech Startup of Biotechnology based on the campus of the University of Poitiers, Southwest of France.
The goals of the startup are to understand the physiology & the physiopathology of the Central Nervous System (CNS) through Research, Development & Treatment.
For that Research PIECES proposes preclinical biological & innovative models to dissect molecular, cellular and tissular mechanisms in a physiological 3D-living tissue environment.
One of our main mission is to propose preclinical innovative models to find the future therapeutic molecules against neurological diseases (neurodegenerative diseases, cancer, infectious diseases, etc.).
Our models are :
- robust & translatable
- physiological
- customized
- an alternative to animal models
They can be used :
- in all the different steps of the early drug discovery (screening, lead of molecules, formulation, test of toxicity, etc.)
- for pathological models of neurodegenerative diseases (Parkinson, Dementia with Lewy Bodies, Multiple Atrophy System, Alzheimer, etc.), cancer (glioblastome, etc.), etc.
- to understand the impact of the environment on the CNS with the role of pesticides, endocrine disruptors, etc.
- For the Army (against neurotoxins)
- For the Veterinary Industry
After a 1st achieved R&D phase, our 1st models are now available on the market. More complex models of pathologies are still in R&D and will come soon!
Because understanding physiopathology, better diagnosis & finding treatments are major challenges for the medicine of tomorrow, there is a real expectation for efficient preclinical robust & translatable models to BETTER approach human physiology/physiopathology & to allow a BETTER environmental risk prevention.
Research PIECES has the innovation to answer these questions!
And because together we are stronger, one of the main objectives of the startup is also to raise awareness the general public about Research, Development & Therapeutics.
Découvrez des solutions innovantes en biotechnologie et recherche.
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
Innovaud
International Trade and Development (Auto) |
Innovaud
International Trade and Development (Auto) |
Other
30 Apr 2026 |
|
|
Roche
Pharmaceutical, Biotechnology, Biotechnology Research (Auto) |
Roche
Pharmaceutical, Biotechnology, Biotechnology Research (Auto) |
Other
30 Apr 2026 |
|
|
Business France
National and local authorities, Government Administration (Auto) |
Business France
National and local authorities, Government Administration (Auto) |
Other
30 Apr 2026 |
|
|
Groupe Roullier
Farming (Auto) |
Groupe Roullier
Farming (Auto) |
Other
24 Feb 2026 |
|
|
Crédit Agricole de la Touraine et du Poitou
Banking (Auto) |
Crédit Agricole de la Touraine et du Poitou
Banking (Auto) |
Other
26 Nov 2025 |
|
|
ALLIS-NA | Alliance Innovation Santé Nouvelle-Aquitaine
Biotechnology Research (Auto) |
ALLIS-NA | Alliance Innovation Santé Nouvelle-Aquitaine
Biotechnology Research (Auto) |
Other
29 May 2026 |
|
|
AQUITI Gestion
Startup accelerator & VC, Financial Services (Auto) |
AQUITI Gestion
Startup accelerator & VC, Financial Services (Auto) |
Other
31 Jan 2026 |
|
|
Grand Poitiers Communauté Urbaine
Government Administration (Auto), EPCI-50K, French Urban Community |
Grand Poitiers Communauté Urbaine
Government Administration (Auto), EPCI-50K, French Urban Community |
Other
31 Jan 2026 |
|
|
Le Réseau des Carnot
Research Services (Auto) |
Le Réseau des Carnot
Research Services (Auto) |
Other
24 Feb 2026 |
|
|
ADI Nouvelle-Aquitaine | Agence de Développement et d’Innovation
Business Consulting and Services (Auto) |
ADI Nouvelle-Aquitaine | Agence de Développement et d’Innovation
Business Consulting and Services (Auto) |
Other
26 Nov 2025 |
|
|